Detailed Information

Cited 14 time in webofscience Cited 17 time in scopus
Metadata Downloads

Standardization of the Korean version of the patient health Questionnaire-4 (PHQ-4)

Full metadata record
DC FieldValueLanguage
dc.contributor.authorKim, Hyoun-Wook-
dc.contributor.authorShin, Cheol min-
dc.contributor.authorLee, Seung-Hoon-
dc.contributor.authorHan, Changsu-
dc.date.available2021-03-22T02:40:12Z-
dc.date.issued2021-02-
dc.identifier.issn1738-1088-
dc.identifier.issn2093-4327-
dc.identifier.urihttps://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/52027-
dc.description.abstractObjective: The Patient Health Questionnaire-4 (PHQ-4) has been used for screening owing to ease of use and brevity. In this study, we developed the Korean version of the PHQ-4 and tested its validity. Methods: One hundred sixteen new adult outpatients at the Department of Psychiatry of the Korea University Ansan Hospital participated in the study. We simultaneously administered other depression/anxiety scales: the Hamilton Rating Scale for Depression, the Hamilton Anxiety Scale, the Beck Depression Inventory, and the Beck Anxiety Inventory. Results: The mean PHQ-4 score was 6.52 (standard deviation = 3.45). Cronbach's a was 0.792, and the intraclass correlation coefficient of test and 2-week interval retest was 0.827 (p < 0.01). The Pearson correlation coefficients between the PHQ-4 total score and other depression/anxiety scales were all over 0.6. Confirmatory factorial analysis showed acceptable convergent validity and reliability but questionable discriminant validity for some model fit values. Conclusion: The Korean version of the PHQ-4 has sufficient internal consistency, test-retest reliability, and construct validity, but its two-factor structure showed incompleteness. However, we suggest that it should be used as a brief screening measure for common psychiatric distress that warrants further detailed assessment, but not to separately assess the severity of depression and anxiety symptoms.-
dc.format.extent8-
dc.language영어-
dc.language.isoENG-
dc.publisher대한정신약물학회-
dc.titleStandardization of the Korean version of the patient health Questionnaire-4 (PHQ-4)-
dc.typeArticle-
dc.publisher.location대한민국-
dc.identifier.doi10.9758/CPN.2021.19.1.104-
dc.identifier.scopusid2-s2.0-85101398181-
dc.identifier.wosid000614138000010-
dc.identifier.bibliographicCitationClinical Psychopharmacology and Neuroscience, v.19, no.1, pp 104 - 111-
dc.citation.titleClinical Psychopharmacology and Neuroscience-
dc.citation.volume19-
dc.citation.number1-
dc.citation.startPage104-
dc.citation.endPage111-
dc.type.docTypeArticle-
dc.identifier.kciidART002689611-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.description.journalRegisteredClasskci-
dc.relation.journalResearchAreaNeurosciences & Neurology-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.relation.journalWebOfScienceCategoryNeurosciences-
dc.relation.journalWebOfScienceCategoryPharmacology & Pharmacy-
dc.subject.keywordPlusMAJOR DEPRESSIVE DISORDER-
dc.subject.keywordPlusPRIMARY-CARE-
dc.subject.keywordPlusANXIETY DISORDERS-
dc.subject.keywordPlusMENTAL-DISORDERS-
dc.subject.keywordPlusSCREENING SCALE-
dc.subject.keywordPlusPREVALENCE-
dc.subject.keywordPlusCOMORBIDITY-
dc.subject.keywordPlusDISABILITY-
dc.subject.keywordPlusVALIDITY-
dc.subject.keywordPlusPOPULATION-
dc.subject.keywordAuthorPatient Health Questionnaire-4-
dc.subject.keywordAuthorStandardization-
dc.subject.keywordAuthorDepression-
dc.subject.keywordAuthorAnxiety-
dc.subject.keywordAuthorScreening-
Files in This Item
There are no files associated with this item.
Appears in
Collections
2. Clinical Science > Department of Psychiatry > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Han, Changsu photo

Han, Changsu
Ansan Hospital (Department of Psychiatry, Ansan Hospital)
Read more

Altmetrics

Total Views & Downloads

BROWSE